Axcelis Technologies shares fall 1.26% after-hours following the launch of new ion implant product platforms.

Axcelis Technologies, Inc. dropped 1.26% in after-hours trading, following the announcement of the launch of the Company's new Purion Power Series+ ion implant product platform, designed to improve device performance and increase productivity for next generation power devices. The company also announced the launch of the GSD Ovation ES high current ion implanter, targeted for engineered substrates, which offers superior flexibility and capital efficiency.